We previously identified lnc-β-catm as a modulator as β-catenin stability in liver cancer and TICs, via promoting the methylation of β-catenin35, and here we investigated whether lactic acid promoted the expression of lnc-β-catm. The gene discussed is BCAT2; the disease is liver cancer.